Prudential Financial
ANAB icon

Prudential Financial’s AnaptysBio ANAB Stock Holding History

Prudential Financial’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.8M Buy
85,932
+21,882
+34% +$1.33M 0.01% 925
2026
Q1 		$3.55M Buy
+64,050
New +$3.45M ﹤0.01% 1070
2019
Q2 		– Sell
-2,817
Closed -$206K – 2455
2019
Q1 		$206K Buy
+2,817
New +$194K ﹤0.01% 2314

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Prudential Financial's ANAB Position: Q2 2026 in Review

Prudential Financial increased its AnaptysBio (ANAB) stake by 34% in Q2 2026, buying an estimated $1.33M and bringing the position to 85,932 shares worth $5.8M. The position accounts for 0.01% of the portfolio, ranked #925.

Prudential Financial first reported a position in ANAB in Q1 2019 and has held it in 3 quarters since. 214 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Prudential Financial held 85,932 shares of AnaptysBio worth $5.8M as of Q2 2026.
  • Prudential Financial bought 21,882 AnaptysBio shares in Q2 2026, an estimated $1.33M.
  • AnaptysBio made up 0.01% of Prudential Financial's portfolio in Q2 2026, its #925 holding.
  • Prudential Financial first reported a position in AnaptysBio in Q1 2019 and has held it in 3 quarters since.
  • 214 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.